Evaluation of Specific Immune Responses to BoNT/A and Tetanus Toxoid in Patients Undergoing Treatment for Neurologic Disorders

Publisher： Bentham Science Publishers

E-ISSN： 2212-3873|12|3|268-273

ISSN： 1871-5303

Source： Endocrine, Metabolic & Immune Disorders-Drug Targets (Formerly Current Drug Targets - Immune, Endocrine & Metabolic Disorders), Vol.12, Iss.3, 2012-09, pp. : 268-273

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Dextran microspheres could enhance immune responses against PLGA nanospheres encapsulated with tetanus toxoid and Quillaja saponins after nasal immunization in rabbit

By Mohaghegh Maliheh   Tafaghodi Mohsen  

Pharmaceutical Development and Technology, Vol. 16, Iss. 1, 2011-02 ,pp. : 36-43

Informa Healthcare

Access to resources Recommend Favorite

8-Hydroxyquinoline and Hydroxamic Acid Inhibitors of Botulinum Neurotoxin BoNT/A

By  

Current Topics in Medicinal Chemistry, Vol. 14, Iss. 18, 2014-09 ,pp. : 2094-2102

Bentham Science Publishers

Access to resources Recommend Favorite

Editorial (Thematic Issue: Inhibition of Botulinum Neurotoxin BoNT/A)

By  

Current Topics in Medicinal Chemistry, Vol. 14, Iss. 18, 2014-09 ,pp. : 2043-2043

Bentham Science Publishers

Access to resources Recommend Favorite

Correlation Between In Vitro Release and In Vivo Immune Response from Biodegradable Polymer Particles Entrapping Tetanus Toxoid

By Raghuvanshi Rajeev S.   Singh Om   Panda Amulya K.  

Drug Delivery, Vol. 9, Iss. 2, 2002-04 ,pp. : 113-120

Informa Healthcare

Access to resources Recommend Favorite

Short-term atorvastatin increases the immune response to the tetanus toxoid vaccine in healthy volunteers

By  

Inpharma, Vol. 1, Iss. 1540, 2006-01 ,pp. : 6-6

Adis International

Access to resources Recommend Favorite